Global Insulin Syringes Market Research Report 2019
Table of Contents
Executive Summary
1 Insulin Syringes Market Overview
- 1.1 Product Overview and Scope of Insulin Syringes
- 1.2 Insulin Syringes Segment by Type
- 1.2.1 Global Insulin Syringes Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 3/10 cc syringe
- 1.2.3 1/2 cc syringe
- 1.2.4 1 cc syringe
- 1.2.5 Others
- 1.3 Insulin Syringes Segment by Application
- 1.3.1 Insulin Syringes Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Homecare
- 1.3.4 Others
- 1.4 Global Insulin Syringes Market by Region
- 1.4.1 Global Insulin Syringes Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Insulin Syringes Market Size
- 1.5.1 Global Insulin Syringes Revenue (2014-2025)
- 1.5.2 Global Insulin Syringes Production (2014-2025)
2 Global Insulin Syringes Market Competition by Manufacturers
- 2.1 Global Insulin Syringes Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Insulin Syringes Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Insulin Syringes Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Insulin Syringes Production Sites, Area Served, Product Types
- 2.5 Insulin Syringes Market Competitive Situation and Trends
- 2.5.1 Insulin Syringes Market Concentration Rate
- 2.5.2 Insulin Syringes Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Insulin Syringes Production Market Share by Regions
- 3.1 Global Insulin Syringes Production Market Share by Regions
- 3.2 Global Insulin Syringes Revenue Market Share by Regions (2014-2019)
- 3.3 Global Insulin Syringes Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Insulin Syringes Production
- 3.4.1 North America Insulin Syringes Production Growth Rate (2014-2019)
- 3.4.2 North America Insulin Syringes Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Insulin Syringes Production
- 3.5.1 Europe Insulin Syringes Production Growth Rate (2014-2019)
- 3.5.2 Europe Insulin Syringes Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Insulin Syringes Production (2014-2019)
- 3.6.1 China Insulin Syringes Production Growth Rate (2014-2019)
- 3.6.2 China Insulin Syringes Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Insulin Syringes Production (2014-2019)
- 3.7.1 Japan Insulin Syringes Production Growth Rate (2014-2019)
- 3.7.2 Japan Insulin Syringes Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Insulin Syringes Consumption by Regions
- 4.1 Global Insulin Syringes Consumption by Regions
- 4.2 North America Insulin Syringes Consumption (2014-2019)
- 4.3 Europe Insulin Syringes Consumption (2014-2019)
- 4.4 China Insulin Syringes Consumption (2014-2019)
- 4.5 Japan Insulin Syringes Consumption (2014-2019)
5 Global Insulin Syringes Production, Revenue, Price Trend by Type
- 5.1 Global Insulin Syringes Production Market Share by Type (2014-2019)
- 5.2 Global Insulin Syringes Revenue Market Share by Type (2014-2019)
- 5.3 Global Insulin Syringes Price by Type (2014-2019)
- 5.4 Global Insulin Syringes Production Growth by Type (2014-2019)
6 Global Insulin Syringes Market Analysis by Applications
- 6.1 Global Insulin Syringes Consumption Market Share by Application (2014-2019)
- 6.2 Global Insulin Syringes Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Insulin Syringes Business
- 7.1 Novo Nordisk
- 7.1.1 Novo Nordisk Insulin Syringes Production Sites and Area Served
- 7.1.2 Insulin Syringes Product Introduction, Application and Specification
- 7.1.3 Novo Nordisk Insulin Syringes Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Sanofi
- 7.2.1 Sanofi Insulin Syringes Production Sites and Area Served
- 7.2.2 Insulin Syringes Product Introduction, Application and Specification
- 7.2.3 Sanofi Insulin Syringes Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Eli Lilly and Company
- 7.3.1 Eli Lilly and Company Insulin Syringes Production Sites and Area Served
- 7.3.2 Insulin Syringes Product Introduction, Application and Specification
- 7.3.3 Eli Lilly and Company Insulin Syringes Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Biocon Ltd
- 7.4.1 Biocon Ltd Insulin Syringes Production Sites and Area Served
- 7.4.2 Insulin Syringes Product Introduction, Application and Specification
- 7.4.3 Biocon Ltd Insulin Syringes Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Ypsomed AG
- 7.5.1 Ypsomed AG Insulin Syringes Production Sites and Area Served
- 7.5.2 Insulin Syringes Product Introduction, Application and Specification
- 7.5.3 Ypsomed AG Insulin Syringes Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Wockhardt Ltd
- 7.6.1 Wockhardt Ltd Insulin Syringes Production Sites and Area Served
- 7.6.2 Insulin Syringes Product Introduction, Application and Specification
- 7.6.3 Wockhardt Ltd Insulin Syringes Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Medtronic Plc
- 7.7.1 Medtronic Plc Insulin Syringes Production Sites and Area Served
- 7.7.2 Insulin Syringes Product Introduction, Application and Specification
- 7.7.3 Medtronic Plc Insulin Syringes Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Abbott Laboratories
- 7.8.1 Abbott Laboratories Insulin Syringes Production Sites and Area Served
- 7.8.2 Insulin Syringes Product Introduction, Application and Specification
- 7.8.3 Abbott Laboratories Insulin Syringes Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Animas Corporation
- 7.9.1 Animas Corporation Insulin Syringes Production Sites and Area Served
- 7.9.2 Insulin Syringes Product Introduction, Application and Specification
- 7.9.3 Animas Corporation Insulin Syringes Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 F. Hoffmann-La Roche
- 7.10.1 F. Hoffmann-La Roche Insulin Syringes Production Sites and Area Served
- 7.10.2 Insulin Syringes Product Introduction, Application and Specification
- 7.10.3 F. Hoffmann-La Roche Insulin Syringes Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
- 7.11 BD
8 Insulin Syringes Manufacturing Cost Analysis
- 8.1 Insulin Syringes Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Insulin Syringes
- 8.4 Insulin Syringes Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Insulin Syringes Distributors List
- 9.3 Insulin Syringes Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Insulin Syringes Market Forecast
- 11.1 Global Insulin Syringes Production, Revenue Forecast
- 11.1.1 Global Insulin Syringes Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Insulin Syringes Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Insulin Syringes Price and Trend Forecast (2019-2025)
- 11.2 Global Insulin Syringes Production Forecast by Regions (2019-2025)
- 11.2.1 North America Insulin Syringes Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Insulin Syringes Production, Revenue Forecast (2019-2025)
- 11.2.3 China Insulin Syringes Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Insulin Syringes Production, Revenue Forecast (2019-2025)
- 11.3 Global Insulin Syringes Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Insulin Syringes Consumption Forecast (2019-2025)
- 11.3.2 Europe Insulin Syringes Consumption Forecast (2019-2025)
- 11.3.3 China Insulin Syringes Consumption Forecast (2019-2025)
- 11.3.4 Japan Insulin Syringes Consumption Forecast (2019-2025)
- 11.4 Global Insulin Syringes Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Insulin Syringes Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
An insulin syringe aids in delivering insulin to diabetic patients in required doses. The insulin syringes consist of three parts-a needle, a barrel, and a plunger, and is available in various sizes. The size of the insulin syringe is selected based on the desired dosage of insulin to be administered to diabetic patients.
The major factors that fuel the growth of the market are the rising aging population and increasing number of diabetic patients globally. In addition, increasing incidence of obesity and people adopting an unhealthy lifestyle supplement the market growth.
The global Insulin Syringes market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Insulin Syringes volume and value at global level, regional level and company level. From a global perspective, this report represents overall Insulin Syringes market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Novo Nordisk
Sanofi
Eli Lilly and Company
Biocon Ltd
Ypsomed AG
Wockhardt Ltd
Medtronic Plc
Abbott Laboratories
Animas Corporation
F. Hoffmann-La Roche
BD
Segment by Regions
North America
Europe
China
Japan
Segment by Type
3/10 cc syringe
1/2 cc syringe
1 cc syringe
Others
Segment by Application
Hospital
Homecare
Others